Endoscopy & Procedures · Article 171

How Should DOACs Be Managed Before and After Endoscopy?

DOAC endoscopy requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

DOAC endoscopy clinical reference — Related free clinical resource: Endoscopy and Diagnostic Imaging.

DOAC endoscopy: practical clinical approach

This page focuses on DOAC endoscopy with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for DOAC endoscopy

Clinical takeaway: For DOAC endoscopy, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Direct oral anticoagulants should usually be temporarily interrupted for elective endoscopy when a clinically meaningful bleeding-risk procedure is planned. Timing depends on the specific drug, renal function and procedure risk because DOACs have short half-lives and rapid onset. Low-risk diagnostic procedures often require little or no interruption; high-risk interventions such as large polypectomy, EMR, ESD or sphincterotomy require a longer drug-free interval and delayed restart until hemostasis is secure. Routine heparin bridging is not used for DOACs.

Know the drug and kidney function

Dabigatran clearance is particularly dependent on renal function; interruption intervals may therefore need to be longer.

Procedure risk determines the plan

Diagnostic endoscopy and biopsy are low risk; large polypectomy, EMR/ESD and sphincterotomy are higher risk.

Restart is as important as stopping

Because anticoagulant effect returns quickly, restarting too early after a high-risk defect can provoke bleeding, while unnecessary delay increases thrombotic risk.

Practical clinical algorithm

1. Identify DOAC, indication, last dose and renal function.

2. Classify procedure bleeding risk.

3. Use a short drug-specific interruption for higher-risk procedures.

4. Do not use routine heparin bridging.

5. Restart when adequate hemostasis is secure—often later after high-risk resection than after diagnostic procedures.

Common mistakes to avoid

Using one interruption interval for all DOACs.
Ignoring renal dysfunction.
Bridging a DOAC with heparin routinely.
Restarting immediately after large EMR.
Holding the drug for a week unnecessarily.

Trainee takeaway

DOAC management is a short, pharmacology-based interruption strategy—not a prolonged warfarin-style washout.

Frequently asked questions

Do all DOACs need to be stopped for diagnostic EGD?

Not always; low-risk procedures may require minimal interruption depending on protocol.

Should DOACs be bridged?

No, routine heparin bridging is not appropriate.

When should they restart?

After adequate hemostasis, with timing matched to procedure bleeding risk.

References

1. Thomson ABR. Clinical Pharmacology, Physiology and Pathophysiology: Gastroenterology, Hepatology, and Pancreaticobiliary Disorders. CAPstone Academic Publishers; 2024.

2. Thomson ABR. Endoscopy and Diagnostic Imaging. Part I. CAPstone Academic Publishers; 2012.

3. Abraham NS, et al. ACG-CAG Clinical Practice Guideline. Am J Gastroenterol. 2022;117:542-558.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions